Subclinical diagnosis of cisplatin-induced ototoxicity with biomarkers

[1]  I. Pipinos,et al.  EFFECTS OF ASSISTIVE TENNIS SHOES ON GROUND REACTION FORCE FOR PATIENTS WITH PERIPHERAL ARTERY DISEASE DURING WALKING , 2022, Innovation in Aging.

[2]  E. Skoe,et al.  Noise exposure levels predict blood levels of the inner ear protein prestin , 2022, Scientific Reports.

[3]  M. Jalali,et al.  Effect of cisplatin chemotherapy on the inner ear function and serum prestin concentration , 2021, European Archives of Oto-Rhino-Laryngology.

[4]  E. Skoe,et al.  Reliability of Serological Prestin Levels in Humans and its Relation to Otoacoustic Emissions, a Functional Measure of Outer Hair Cells , 2021, Ear and hearing.

[5]  Xiaoling Xuan,et al.  A Preliminary Report on the Investigation of Prestin as a Biomarker for Idiopathic Sudden Sensorineural Hearing Loss , 2020, Ear, nose, & throat journal.

[6]  L. Cunningham,et al.  An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity , 2019, Hearing Research.

[7]  J. Dyhrfjeld-Johnsen,et al.  Noise-induced trauma produces a temporal pattern of change in blood levels of the outer hair cell biomarker prestin , 2019, Hearing Research.

[8]  B. Demirci,et al.  Utilizing prestin as a predictive marker for the early detection of outer hair cell damage. , 2018, American journal of otolaryngology.

[9]  K. Parham,et al.  Prestin as an Otologic Biomarker of Cisplatin Ototoxicity in a Guinea Pig Model , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  Alec N. Salt,et al.  Communication pathways to and from the inner ear and their contributions to drug delivery , 2017, Hearing Research.

[11]  K. Parham,et al.  Changes in Serum Prestin Concentration After Exposure to Cisplatin. , 2017, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[12]  M. Hall,et al.  Cisplatin is retained in the cochlea indefinitely following chemotherapy , 2017, Nature Communications.

[13]  J. Dyhrfjeld-Johnsen,et al.  Outer Hair Cell Molecular Protein, Prestin, as a Serum Biomarker for Hearing Loss: Proof of Concept , 2016, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[14]  K. Parham.  Prestin as a biochemical marker for early detection of acquired sensorineural hearing loss. , 2015, Medical hypotheses.

[15]  John S. Oghalai,et al.  Prestin Regulation and Function in Residual Outer Hair Cells after Noise-Induced Hearing Loss , 2013, PloS one.

[16]  A. Brunetto,et al.  The use of high‐frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin‐based chemotherapy , 2013, Pediatric blood & cancer.

[17]  Miao Zhu,et al.  Prestin up-regulation in chronic salicylate (aspirin) administration: An implication of functional dependence of prestin expression , 2008, Cellular and Molecular Life Sciences.

[18]  Guang-di Chen.  Prestin gene expression in the rat cochlea following intense noise exposure , 2006, Hearing Research.

[19]  J. Schellens,et al.  Relationship between cisplatin administration and the development of ototoxicity. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Knight,et al.  Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Lassalle,et al.  Platinum Compound-Related Ototoxicity in Children: Long-Term Follow-Up Reveals Continuous Worsening of Hearing Loss , 2004, Journal of pediatric hematology/oncology.

[22]  R. Mayeux.  Biomarkers: Potential uses and limitations , 2004, NeuroRX.

[23]  L. Lehmann,et al.  Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma , 1998, Bone Marrow Transplantation.

[24]  M. Tableman,et al.  Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. , 1995, Neurosurgery.

[25]  J. Henry,et al.  High-frequency monitoring for early detection of cisplatin ototoxicity. , 1993, Archives of otolaryngology--head & neck surgery.

[26]  H. Meuwissen,et al.  Therapeutic Review : The Ototoxic Antibiotics , 1967 .

[27]  B. C. Cox,et al.  Whole Mount Dissection and Immunofluorescence of the Adult Mouse Cochlea. , 2016, Journal of visualized experiments : JoVE.

[28]  Melanie Volkamer,et al.  Proof of Concept , 2009 .